FILAMENT HEALTH AND PSYENCE ANNOUNCE WORLDWIDE LICENSING AGREEMENT OF PSILOCYBIN CAPSULE...

PsyBio Therapeutics Takes Initial Step to Help Protect the Sonoran Desert...

MIND CURE ENTERS INTO BINDING LETTER OF INTENT WITH LNG ENERGY...

Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic...

Psyence Group Announces Closing of Second Tranche of Private Placement and...

Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets...

Algernon Pharmaceuticals Receives U.S. FDA Orphan Drug Designation for Ifenprodil for...

Ehave Shareholder from CEO Ben Kaplan and Corporate Update

Israeli Based Biotech Company Clearmind Completes IND-Enabling Studies for CMND-100

Vital 2023: Informational Session and Q&A

Load more